Aurora Cannabis (ACB) Research & Development (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Research & Development of $718996.8 for Q1 2026, up 31.42% year-over-year from $547079.4 in Q1 2025, and down 23.05% quarter-over-quarter from $934363.4 in Q4 2025.
Aurora Cannabis (ACB) Research & Development (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Research & Development for 10 consecutive years, with $718996.8 the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development rose 31.42% year-over-year to $718996.8; the TTM figure through Mar 2026 stood at $2.9 million (up 9.82% YoY), while the FY2026 annual figure was $2.9 million, up 10.91% from the prior year.
- Research & Development fell to $718996.8 in Q1 2026 per ACB's latest filing, from $934363.4 in the prior quarter.
- Across five years, Research & Development topped out at $3.0 million in Q4 2022 and bottomed at $547079.4 in Q1 2025.
- Historically, Research & Development has averaged $1.1 million across 5 years, with a median of $714727.1 in 2024.
- Annual changes were most pronounced in 2022 — Research & Development surged 135.15% — and 2023, when it slumped 81.05%.
- Aurora Cannabis' Research & Development stood at $3.0 million in 2022, then plunged by 81.05% to $574406.8 in 2023, then gained by 15.78% to $665023.9 in 2024, then soared by 40.5% to $934363.4 in 2025, then slipped by 23.05% to $718996.8 in 2026.
- Business Quant data shows ACB's Research & Development at $718996.8 in Q1 2026, $934363.4 in Q4 2025, and $656878.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Aurora Cannabis | 235.30 Mn | 162.99 Mn | 25.75 Mn | 680,272.68 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 718,996.81 |
| Dec 31, 2025 | 934,363.43 |
| Sep 30, 2025 | 656,878.04 |
| Jun 30, 2025 | 598,299.66 |
| Mar 31, 2025 | 547,079.43 |
| Dec 31, 2024 | 665,023.85 |
| Sep 30, 2024 | 714,727.07 |
| Jun 30, 2024 | 721,635.72 |
| Mar 31, 2024 | 551,390.11 |
| Dec 31, 2023 | 574,406.78 |
| Sep 30, 2023 | 705,650.22 |
| Dec 31, 2022 | 3.03 Mn |
| Sep 30, 2022 | 2.42 Mn |
| Jun 30, 2022 | 1.56 Mn |
| Mar 31, 2022 | 2.08 Mn |
| Dec 31, 2021 | 1.29 Mn |
| Sep 30, 2021 | 2.92 Mn |
| Jun 30, 2021 | 2.47 Mn |
| Mar 31, 2021 | 2.68 Mn |
| Dec 31, 2020 | 1.87 Mn |